Diabetes, Vol 36, Issue 6 689-692, Copyright © 1987 by American Diabetes Association

ARTICLES

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

RP Donahue, RD Abbott, DM Reed and K Yano

Since 1965, the Honolulu Heart Program has followed 8006 men of Japanese ancestry, aged 45-70 yr at study entry, for the development of cardiovascular disease. To investigate the role of glucose concentration 1 h after a 50-g challenge on the risk of fatal coronary heart disease (CHD) and nonfatal myocardial infarction (MI), 6394 nondiabetic men were followed for 12 yr for the first development of CHD. The rate of fatal CHD increased linearly with amount of glucose. Men in the fourth quintile of postchallenge glucose (157-189 mg/dl) had twice the age-adjusted risk of fatal CHD of those in the lowest quintile (P less than .05). Relative risk increased to threefold among those in the top quintile and remained statistically significant after adjustment for other risk factors including body mass, total cholesterol, hypertension, left ventricular hypertrophy, and hematocrit (P less than .001). When glucose was considered as a linear term in the proportional hazards model, a highly significant relation was noted with fatal CHD alone and when combined with nonfatal MI (P less than .001). We conclude that a continuously increasing risk gradient exists between postchallenge glucose and subsequent CHD that is independent of other known risk factors.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. R. Dasu, S. Devaraj, and I. Jialal High glucose induces IL-1beta expression in human monocytes: mechanistic insights Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E337 - E346. [Abstract] [Full Text] [PDF]

				D. J. A. Jenkins, C. W. C. Kendall, A. R. Josse, S. Salvatore, F. Brighenti, L. S. A. Augustin, P. R. Ellis, E. Vidgen, and A. V. Rao Almonds Decrease Postprandial Glycemia, Insulinemia, and Oxidative Damage in Healthy Individuals J. Nutr., December 1, 2006; 136(12): 2987 - 2992. [Abstract] [Full Text] [PDF]

				P. Lucotti, E. Setola, L. D. Monti, E. Galluccio, S. Costa, E. P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E906 - E912. [Abstract] [Full Text] [PDF]

				S. Edelman, S. Garg, J. Frias, D. Maggs, Y. Wang, B. Zhang, S. Strobel, K. Lutz, and O. Kolterman A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes Diabetes Care, October 1, 2006; 29(10): 2189 - 2195. [Abstract] [Full Text] [PDF]

				H. Wagner, M. Degerblad, A. Thorell, J. Nygren, A. Stahle, J. Kuhl, T. B. Brismar, J. Ohrvik, S. Efendic, and P. N. Bavenholm Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes Diabetes Care, July 1, 2006; 29(7): 1471 - 1477. [Abstract] [Full Text] [PDF]

				E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes Diabetes Care, July 1, 2006; 29(7): 1486 - 1490. [Abstract] [Full Text] [PDF]

				C. Robertson Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control. The Diabetes Educator, May 1, 2006; 32(3): 423 - 432. [Abstract] [Full Text] [PDF]

				R. J. Heine, L. F. Van Gaal, D. Johns, M. J. Mihm, M. H. Widel, R. G. Brodows, and for the GWAA Study Group* Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial Ann Intern Med, October 18, 2005; 143(8): 559 - 569. [Abstract] [Full Text] [PDF]

				The Diabetes Prevention Program Research Group Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program Diabetes Care, April 1, 2005; 28(4): 888 - 894. [Abstract] [Full Text] [PDF]

				A. Ceriello Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat? Diabetes, January 1, 2005; 54(1): 1 - 7. [Abstract] [Full Text] [PDF]

				A. Ceriello, M. Hanefeld, L. Leiter, L. Monnier, A. Moses, D. Owens, N. Tajima, J. Tuomilehto, and for the International Prandial Glucose Regulation Postprandial Glucose Regulation and Diabetic Complications Arch Intern Med, October 25, 2004; 164(19): 2090 - 2095. [Abstract] [Full Text] [PDF]

				F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance JAMA, April 21, 2004; 291(15): 1857 - 1863. [Abstract] [Full Text] [PDF]

				V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]

				J. Davidson Should Postprandial Glucose Be Measured and Treated to a Particular Target? Yes. Diabetes Care, June 1, 2003; 26(6): 1919 - 1921. [Full Text] [PDF]

				H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al. Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia Diabetes Care, April 1, 2003; 26(4): 1211 - 1215. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25-26 August 2002, Washington, DC Diabetes Care, April 1, 2003; 26(4): 1297 - 1303. [Full Text] [PDF]

				P. Gresele, G. Guglielmini, M. De Angelis, S. Ciferri, M. Ciofetta, E. Falcinelli, C. Lalli, G. Ciabattoni, G. Davi, and G. B. Bolli Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1013 - 1020. [Abstract] [Full Text] [PDF]

				C. Invitti, G. Guzzaloni, L. Gilardini, F. Morabito, and G. Viberti Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents Diabetes Care, January 1, 2003; 26(1): 118 - 124. [Abstract] [Full Text] [PDF]

				C. Saloranta, C. Guitard, E. Pecher, P. de Pablos-Velasco, K. Lahti, P. Brunel, and L. Groop Nateglinide Improves Early Insulin Secretion and Controls Postprandial Glucose Excursions in a Prediabetic Population Diabetes Care, December 1, 2002; 25(12): 2141 - 2146. [Abstract] [Full Text] [PDF]

				J. B. Meigs, D. M. Nathan, R. B. D'Agostino Sr, and P. W.F. Wilson Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk: The Framingham Offspring Study Diabetes Care, October 1, 2002; 25(10): 1845 - 1850. [Abstract] [Full Text] [PDF]

				N. Mikhail, J. A. Beckman, M. A. Creager, and P. Libby Postprandial Hyperglycemia and Risk of Atherosclerosis JAMA, August 28, 2002; 288(8): 955 - 955. [Full Text] [PDF]

				R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus Ann Intern Med, August 20, 2002; 137(4): 263 - 272. [Abstract] [Full Text] [PDF]

				C. G. Parkin and N. Brooks Is Postprandial Glucose Control Important? Is It Practical In Primary Care Settings? Clin. Diabetes, April 1, 2002; 20(2): 71 - 76. [Abstract] [Full Text] [PDF]

				N. L. Smith, J. I. Barzilay, D. Shaffer, P. J. Savage, S. R. Heckbert, L. H. Kuller, R. A. Kronmal, H. E. Resnick, and B. M. Psaty Fasting and 2-Hour Postchallenge Serum Glucose Measures and Risk of Incident Cardiovascular Events in the Elderly: The Cardiovascular Health Study Arch Intern Med, January 28, 2002; 162(2): 209 - 216. [Abstract] [Full Text] [PDF]

				S. E. Inzucchi Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review JAMA, January 16, 2002; 287(3): 360 - 372. [Abstract] [Full Text] [PDF]

				R. K. Campbell, J. R. White, and D. Nomura The Clinical Importance of Postprandial Hyperglycemia The Diabetes Educator, September 1, 2001; 27(5): 624 - 637. [PDF]

				K.-T. Khaw, N. Wareham, R. Luben, S. Bingham, S. Oakes, A. Welch, and N. Day Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) BMJ, January 6, 2001; 322(7277): 15 - 15. [Abstract] [Full Text] [PDF]

				L. M. Title, P. M. Cummings, K. Giddens, and B. A. Nassar Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2185 - 2191. [Abstract] [Full Text] [PDF]

				J. B. Meigs Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors Am. J. Epidemiol., November 15, 2000; 152(10): 908 - 911. [Abstract] [Full Text] [PDF]

				M. Carlsson, Y. Wessman, P. Almgren, and L. Groop High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1588 - 1594. [Abstract] [Full Text] [PDF]

				G. C. Friesinger II and J. A. Gavin III Diabetes and the cardiologists: a call to action J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1130 - 1133. [Full Text] [PDF]

				J. B. Meigs, M. A. Mittleman, D. M. Nathan, G. H. Tofler, D. E. Singer, P. M. Murphy-Sheehy, I. Lipinska, R. B. D'Agostino, and P. W. F. Wilson Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study JAMA, January 12, 2000; 283(2): 221 - 228. [Abstract] [Full Text] [PDF]

				S. G. Wannamethee, I. J. Perry, and A. G. Shaper Nonfasting Serum Glucose and Insulin Concentrations and the Risk of Stroke Stroke, September 1, 1999; 30(9): 1780 - 1786. [Abstract] [Full Text] [PDF]

				S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text]

				B. Gaster and I. B. Hirsch The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes Arch Intern Med, January 26, 1998; 158(2): 134 - 140. [Abstract] [Full Text] [PDF]

				P. J. Savage Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention Ann Intern Med, January 1, 1996; 124(1_Part_2): 123 - 126. [Abstract] [Full Text]